Cargando…
Cumulative exposure to tacrolimus during early period after liver transplantation does not affect the recurrence of hepatocellular carcinoma
The clinical effects of tacrolimus (TAC) exposure on hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) remain unclear. In this retrospective single centric study, 512 patients who underwent LT for HCC were divided into four groups according to cumulative exposure to tacrolim...
Autores principales: | Kim, Deok-Gie, Yim, Seung Hyuk, Min, Eun-Ki, Choi, Mun Chae, Joo, Dong Jin, Kim, Myoung Soo, Lee, Jae Geun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658176/ https://www.ncbi.nlm.nih.gov/pubmed/37981643 http://dx.doi.org/10.1038/s41598-023-46803-8 |
Ejemplares similares
-
Antiplatelet Drugs on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Choi, Mun Chae, et al.
Publicado: (2022) -
Risk Factors for Cytomegalovirus Infection and Its Impact on Survival after Living Donor Liver Transplantation in South Korea: A Nested Case-Control Study
por: Yim, Seung Hyuk, et al.
Publicado: (2023) -
Predicted Impact of the Model for End-Stage Liver Disease 3.0 in a Region Suffering Severe Organ Shortage
por: Kim, Deok-Gie, et al.
Publicado: (2023) -
Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study
por: Yim, Seung Hyuk, et al.
Publicado: (2023) -
Favourable outcome of pathologic downstaging by locoregional treatment for hepatocellular carcinoma in liver transplantation
por: Kim, Deok Gie, et al.
Publicado: (2019)